SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Centrus Energy Corp. engages in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment includes various components of nuclear fuel to utilities from its global network of suppliers. The Technical Solutions segment offers advanced engineering, design, and manufacturing services to government and private sector customers, and is deploying advanced nuclear fuel production capabilities to power existing, and next-generation reactors around the world. The company was founded in October 1992 and is headquartered in Bethesda, MD.

Centrus Energy Corp - Ordinary Shares - Class A

Centrus Energy Corp 

Centrus shares are drawing attention amid a steep, volatile selloff, with traders blaming share dilution from equity and warrant offerings, a rich valuation, and the cost and execution risks of expanding enrichment capacity. Bulls counter that DOE and commercial fuel contracts support the longer-term domestic nuclear-fuel and HALEU opportunity, while bearish traders question when that growth will translate into results.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Inovios FDA accelerated approval of a competing treatment for recurrent respiratory papillomatosis has raised concerns about competition for Precigens PAPZIMEOS and prompted debate over its potential effect on sales. Traders weigh the rivals dosing advantages against PAPZIMEOS commercial head start, established payer access and stronger first-year response data, while also watching Precigens upcoming earnings for evidence of continued uptake.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A breakout to fresh 52-week highs ahead of the Q3 report has traders focused on BRIUMVIs sales momentum and the possibility of stronger guidance. The community also points to heavy call activity and short interest, while debating whether the rally reflects earnings positioning and momentum or unconfirmed buyout speculation; upcoming subcutaneous BRIUMVI data is another catalyst in view.

Twilio, Inc. engages in the development of communications software, cloud-based platforms, and services. It operates through Twilio Communications and Twilio Segments. The Twilio Communications segment includes the platforms Messaging and Voice. The Twilio Segment involves Segment, Engage, Flex, Email, and others. The company was founded by John Wolthuis, Jeffery G. Lawson, and Evan Cooke in March 2008 and is headquartered in San Francisco, CA.

Twilio Inc - Ordinary Shares Class A

Twilio Inc

Twilios post-earnings selloff follows a Q3 beat and higher full-year outlook, as its Q4 organic growth guidance signaled a slowdown from the prior quarter. Traders are divided between viewing the drop as an overreaction with bounce potential and waiting for the stock to stabilize as investors reassess the growth outlook.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,105,365. The last known price of Bitcoin is 78,059.66839082 USD and is up 0.67 over the last 24 hours. It is currently trading on 12773 active market(s) with $13,095,082,899.62 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

The massive Binance hack and the exchanges resumption of withdrawals have put crypto security, customer outflows, and potential market contagion at the center of Bitcoin discussion. Traders are divided: bears warn of further selling and exchange-liquidity risks, while bulls argue Bitcoins resilience through the incident supports a recovery.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQs large equity raise and stock-funded Elisity acquisition have put dilution and capital allocation at the center of discussion as shares sell off. Some traders see the deal as extending the company into cybersecurity and broader quantum infrastructure, while others question its value per share and want evidence that acquisitions and quantum programs can translate into recurring revenue.

OFFICIAL TRUMP (TRUMP) is a cryptocurrency and operates on the Solana platform. OFFICIAL TRUMP has a current supply of 999,998,809.831273 with 281,866,746.118905 in circulation. The last known price of OFFICIAL TRUMP is 1.73532194 USD and is up 9.97 over the last 24 hours. It is currently trading on 744 active market(s) with $259,407,006.57 traded over the last 24 hours. More information can be found at https://gettrumpmemes.com/.

Trump For President

Discussion centers on the TRUMP meme coins steep decline and claims that it was a pump-and-dump that left retail holders with losses. Bearish traders call it a scam and expect further selling, while some holders argue for accumulation or a speculative rebound.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

The European Lithium acquisition and resulting CRML share issuance are driving debate, with some traders concerned about dilution and potential selling pressure while others see the added cash and assets, including greater ownership of Tanbreez, as a positive. High-borrow-cost and short-squeeze speculation is also prominent, though traders disagree on whether it will lead to sustained buying.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is under pressure after Q3 results raised concerns about weakening trading activity and revenue despite a headline earnings beat, while the Binance hack and crypto-market selloff have added to uncertainty. Traders are split between seeing the breach as a chance for Coinbase to attract users and fearing it will further damage confidence and trading volumes.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Mercks quarterly results beat expectations and the company raised its full-year outlook, prompting bullish reactions alongside attention to the stocks technical strength. Traders also weigh the positive update against longer-term concerns about Keytrudas patent cliff and pipeline growth.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SFM Stock Heads For Worst Week Ever: Sprouts Farmers Market Faces Wall Street’s Ire As Analysts Slash Price Targets On Weak Outlook 

Equity

Analysts questioned Sprouts Farmers Market’s recovery prospects as it reported weakening store sales. 


 Michael Burry Ramped His SFM Stock Position To 3% — Here's Why He Sees 'Long Runway' Despite Near-Term Pain

Burry increased his stake in Sprouts Farmers Market to about 3%, adding shares at around $73 per share. 


Deere Stock Surges on Upbeat Earnings & Guidance: Agri ETFs to Play

Deere (DE) jumps after strong earnings and higher guidance, lifting agriculture ETFs like VEGI, KROP and FTAG as farm and ag-tech stocks gain momentum.

 ETFs in Spotlight as Trump Moves to Mobilize Defense Production Act

Trump invokes the Defense Production Act to secure phosphorus and glyphosate. MOO could gain as domestic agricultural and materials players ramp up. 

ETFs in Spotlight as Deere Slumps After Q4 Earnings Fall 14% Y/Y

VEGI and other DE-heavy ETFs draw attention as Deere's shares slide after a 14% drop in quarterly earnings.

Retail Investors Remain Neutral On Beyond Meat Stock Despite Restructuring Report And 13% Fall In Stock

For the quarter-ended March 2024, the company’s cash and cash equivalents balance, including restricted cash, stood at $173.50 million. Retail investors remain concerned that the company can’t generate cash from its operations and will need to get it through more dilutive means.

Global X Funds - Global X AgTech & Food Innovation ETF

Neutral Sentiment

<ul class="summary-bullets"><li>Goldman Sachs cut its Sprouts price target citing concerns over weaker Q4 sales and margins.&nbsp;</li><li>Roth Capital cited rising competition and uncertainty over consumer response to planned pricing investments.</li><li>Bank of America downgraded Sprouts to ‘Underperform’ from ‘Buy’ and slashed its price target to $47 from $100.&nbsp;</li></ul>Sprouts Farmers Market (SFM) stock is heading for its worst weekly performance on record as disappointing third-quarter (Q3) results and a weak fourth-quarter outlook fuel Wall Street’s concerns. Four major analyst firms slashed price targets, with two downgrading the stock, citing slowing sales, margin pressures and growing competition as the grocer ramps up pricing investments.&nbsp;<a href="https://stocktwits.com/symbol/SFM">Sprouts Farmers Market stock</a> edged down 0.4% overnight, ahead of Friday. The stock has plunged 27% this week and is also on track for its worst month ever.&nbsp;<h2 class="st-heading-2">Wall Street Turns More Cautious On Sprouts Farmers Market</h2>Goldman Sachs analyst Leah Jordan slashed the price target to $58 from $94 but kept a ‘Buy’ rating. The Q3 earnings miss was expected, but the analyst was surprised by a weak Q4 outlook, which could slow store sales growth and reduce profit margins.&nbsp;In Q3, Sprouts reported $2.3 billion in net sales, up 5% year-on-year. However, comparable-store sales fell 0.9%. Sprouts expects comparable-store sales to decline between 2% and 4% in Q4, with earnings per share of $0.47 - $0.51.“While a challenging consumer environment and the cyclospora disruption affected the quarter, we recognize the need to improve our performance and are taking action to strengthen execution and drive traffic,” said CEO Jack Sinclair.With Nick Konat scheduled to become CEO in January, Goldman Sachs said investors should monitor customer engagement and perceptions of the company's pricing. The firm also highlighted the importance of assessing whether additional spending and upcoming pricing changes can improve customer response.Roth Capital also lowered its target, bringing it down to $56 from $82 while retaining a ‘Neutral’ rating. The firm pointed to disappointing comparable sales and earnings. Although Sprouts plans to increase investments in Q4, Roth sees uncertainty around how shoppers will respond. Intensifying competition and consumers' growing focus on affordability also cloud the company's 2027 outlook.<h2 class="st-heading-2">Bank Of America, RBC Downgrade Sprouts Farmers Market</h2>Bank of America took a more bearish stance, downgrading SFM to ‘Underperform’ from ’Buy’ and cutting its price target to $47 from $100. The analyst linked weaker Q3 comparable-store sales to difficult consumer conditions and disruption linked to a Cyclospora outbreak.&nbsp;The firm expects additional pressure on revenue growth, store traffic and profit. It also warned that Sprouts' efforts to make products more affordable could weigh further on average customer spending in 2027.RBC Capital lowered its rating on SFM to ‘Sector Perform’ from ‘Outperform’ and cut its price target to $49 from $111. The firm pointed to growing grocery competition and uncertainty over whether Sprouts' planned investments will attract more customers.&nbsp;<h2 class="st-heading-2">SFM Stock: Retail View&nbsp;</h2>However, on Stocktwits, retail sentiment around the stock remained ‘extremely bullish.’A user&nbsp;<a href="https://stocktwits.com/Warren1989/message/667620667">said</a>, “Added 1000 shares in premarket at 47.25. Going to sit on this and not look at it for another year. They will get through the rough patch of the fourth quarter, and things will normalize next year. ”SFM stock has cratered 39% year-to-date.&nbsp;Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/sbux-stock-heads-for-third-green-week-ceo-brian-niccol-starbucks-ahead-of-schedule-fiscal-2028-goal/cZUhlW0R9Rz">SBUX Stock Heads For Third Green Week: CEO Says Starbucks Is 'Ahead Of Schedule' In Fiscal 2028 Goal — 'Our Coffeehouses Are Coffeehouses Again'</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Sprouts Farmers Market logo is displayed in the produce section of a Sprouts store.

Sprouts Farmers Market (SFM) stock is heading for its worst weekly performance on record as disappointing third-quarter (Q3) results and a weak fourth-quarter outlook fuel Wall Street’s concerns. Four major analyst firms slashed price targets, with two do

SFM Stock Heads For Worst Week Ever: Sprouts Farmers Market Faces Wall Street’s Ire As Analysts Slash Price Targets On Weak Outlook

Sprouts Farmers Market Inc

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

KROP Global X Funds - Global X AgTech & Food Innovation ETF

Fundamentals

Latest KROP News